Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278889
Status:
COMPLETED
Last Update Posted:
2012-10-24
First Post:
2006-01-17
Brief Title:
Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic AcidLeucovorin F - Fluorouracil and OX - Oxaliplatin FOLFOX
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2007-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-17
First Submit QC Date:
January 17 2006
Study First Post Date:
2006-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-04-06
Disp First Submit QC Date:
April 6 2011
Disp First Post Date:
2011-04-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-09-24
Last Update Post Date:
2012-10-24
Last Update Post Date Type:
ESTIMATED